Cancer Genetics

Cancer Genetics, Inc. (CGI) is a privately held company based in Rutherford, New Jersey, specializing in DNA-based cancer diagnostics. The company employs 116 individuals and reports annual revenue of $50 million. CGI offers a range of diagnostic tests targeting challenging-to-diagnose cancers, including hematological, urogenital, and HPV-associated cancers. They also provide a comprehensive suite of non-proprietary oncology-focused tests and laboratory services. These services cater to a diverse clientele, including prestigious medical institutions, biopharma companies, and biotech firms. CGI distinguishes itself through its proprietary DNA-based cancer tests and a state-of-the-art, CLIA-certified and CAP-accredited reference laboratory. The laboratory holds licensure in multiple states, including New York, and is committed to maintaining the highest standards of clinical excellence. For more information, visit Cancer Genetics' website at cancergenetics.com.